FDA and EMA Push for Predicting Protocol Deviations. How Psychology Can Help
The site team was blindsided. The patient met every inclusion and exclusion criterion, showed no red flags, and even...
The site team was blindsided. The patient met every inclusion and exclusion criterion, showed no red flags, and even...
In 2025, a surge of FDA guidance updates signaled a broader shift in the clinical trial ecosystem. They marked...
The global obesity epidemic has shifted from a public health issue to a fiercely competitive pharmaceutical frontier. With GLP-1...
In August 2024, the FDA rejected the New Drug Application for MDMA-assisted therapy for PTSD, sponsored by Lykos Therapeutics,...
In September 2024, the U.S. Food and Drug Administration (FDA) issued its final guidance titled Conducting Clinical Trials with Decentralized...
Real-world evidence (RWE) is increasingly referenced in regulatory conversations, particularly following the FDA’s 2023 guidance. Roche’s recent FDA clearance...
Pragmatic clinical trials have become one of the industry’s favorite buzzwords, but where’s the real progress? Every year, the...
The journey toward superintelligence unlocks extraordinary capabilities poised to revolutionize medicine and healthcare. These systems can process vast amounts...
The re-election of Donald Trump in 2024 marks the start of a dramatic transformation in healthcare, biotech, and clinical...
This article contains speculative content, opinions, and assumptions about the Walmart Health center that are not confirmed facts. The...